You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 14, July 25, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (39)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Immunologic Disorders
 •Rheumatoid Arthritis
 •Alert me on articles by topic

Paradoxical Effect of Body Mass Index on Survival in Rheumatoid Arthritis

Role of Comorbidity and Systemic Inflammation

Agustín Escalante, MD; Roy W. Haas, PhD; Inmaculada del Rincón, MD, MS

Arch Intern Med. 2005;165:1624-1629.

Background  Despite high cardiovascular mortality in rheumatoid arthritis (RA), few studies of body mass index (BMI) and obesity as risk factors for death in RA have been published.

Methods  We estimated the effect of BMI on survival in a cohort of 779 patients with RA adjusting for comorbidity, RA disease severity, erythrocyte sedimentation rate (ESR), and other potential confounders.

Results  The cohort accrued 123 deaths in 3460 person-years (3.6 deaths per 100 person-years; 95% confidence interval [CI], 3.0-4.2). The BMI was inversely associated with mortality. Patients with BMIs of 30 or higher had the lowest mortality, 1.7 deaths per 100 person-years (95% CI, 1.1-2.5). Mortality was higher in each lower BMI category, reaching its highest rate among patients with BMIs lower than 20 with 15.0 deaths per 100 person-years (95% CI, 9.9-23.0). The survival advantage of high BMI was independent of RA onset age, RA duration, sex, ethnic group, socioeconomic status, smoking status, and use of methotrexate but was lost on adjusting for comorbidity and RA severity. We observed an interaction between BMI and ESR, where the BMI protective influence occurred only if the ESR was low. The BMI x ESR interaction was independent of all covariates, including comorbidity and RA severity.

Conclusions  Body mass has a paradoxical effect on mortality in RA. Patients with high BMI have lower mortality than thinner patients. This effect is mediated in part by comorbidity. The effect of body mass on survival seems to be modified by the level of systemic inflammation.


Author Affiliations: Division of Rheumatology and Clinical Immunology, Department of Medicine, The University of Texas Health Science Center at San Antonio.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rheumatoid cachexia: a clinical perspective
Summers et al.
Rheumatology (Oxford) 2008;47:1124-1131.
ABSTRACT | FULL TEXT  

A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis
van der Helm-van Mil et al.
Ann Rheum Dis 2008;67:769-774.
ABSTRACT | FULL TEXT  

Redefining overweight and obesity in rheumatoid arthritis patients
Stavropoulos-Kalinoglou et al.
Ann Rheum Dis 2007;66:1316-1321.
ABSTRACT | FULL TEXT  

Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis
Otero et al.
Ann Rheum Dis 2006;65:1198-1201.
ABSTRACT | FULL TEXT  

Re: Obesity and cardiovascular risk factors in rheumatoid arthritis
Hall and Dalbeth
Rheumatology (Oxford) 2006;45:782-783.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.